New hope for dementia sufferers

February 8, 2013
Researchers are investigating new ways to treat Alzheimers disease by targeting the blood-brain barrier

(Medical Xpress)—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.

Researchers are investigating new ways to treat Alzheimer's by targeting the blood-brain barrier, which acts as a door to the brain, and is responsible for pumping toxins in the blood away from the brain.

Dr Joseph Nicolazzo, from the Monash Institute of Pharmaceutical Sciences, in collaboration with the University of Washington, is examining pumps at the blood-brain barrier that are known to become dysfunctional in Alzheimer's patients.

This diminished pumping action is believed to result in a build-up of the toxin amyloid in the brain, killing and leading to memory loss associated with Alzheimer's.

The researchers are investigating how to get the pumps working again, to safely filter toxins out of the brain.

"Alzheimer's is the most common form of dementia affecting 300,000 Australians," Dr Nicolazzo said.

"While there are medications that can assist with memory, there is currently no cure that can reverse the disease.

"We hope that unravelling how to get the pumps working again to decrease build-up in the brain will lead to that may cure Alzheimer's disease."

It is believed 900,000 Australians will be affected by Alzheimer's disease by 2050.

Explore further: Advances in research into Alzheimer's disease

Related Stories

Alzheimer’s prevention better than a cure

July 14, 2011

In a new study published in Nature, Dr. Sam Gandy from Mount Sinai Medical Center argues that finding a cure for Alzheimer’s disease may be near impossible and that the best hope for researchers is to focus on prevention, ...

Road block as a new strategy for the treatment of Alzheimer's

August 22, 2011

Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception ...

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.